Glycated albumin (GA) is a candidate for glycemic indicator
to
control prediabetes, the half-life of which is about 2 weeks, which
is neither too long nor too short, considering that there is no longer
any need for daily fingerstick sampling but glucose levels can be
controlled in a relatively short term. Its usefulness as a glycemic
indicator must be widely recognized by developing a simple and miniaturized
GA sensor for point-of-care testing (POCT) devices. In this study,
we propose an aptamer-based capacitive electrode for electrochemical
capacitance spectroscopy (ECS) to specifically detect GA in an enzyme-/antibody-free
manner. As a component of the bioelectrical interface between the
sample solution and the electrode, a densely packed capacitive polyaryl
film coated on a gold electrode contributes to the detection of GA
by the ECS method. In addition, the GA aptamer tethered onto the polyaryl-film-coated
gold electrode is useful for not only specifically capturing GA but
also inducing changes in the concentration of cations released from
the cation/GA aptamer complexes by GA/GA aptamer binding. Also, hydrophilic
poly(ethylene glycol) (PEG) coated on the polyaryl film electrode
in parallel with the GA aptamer prevents interfering proteins such
as human serum albumin (HSA) and immunoglobulin G (IgG) from nonspecifically
absorbing on the polyaryl film electrode. Such a GA aptamer-based
capacitive electrode produces significant signals of GA against HSA
and IgG with the change in GA concentration (0.1, 1, and 10 mg/mL)
detected by the ECS method. This indicates that the ECS method contributes
to the evaluation of the GA level, which is based on the rate of glycation
of albumin. Thus, a platform based on ECS measurement using the aptamer-based
capacitive electrode is useful for protein analysis in an enzyme-/antibody-free
manner.